Výsledky vyhledávání - "V, Alberola Candel"

One Year of Complete Clinical Response in a Metastatic Breast Cancer Patient Treated with a Combination of Lapatinib and Gemcitabine

Autor: J. B. Laforga Canales, V. Alberola Candel, J. Gasent Blesa

Publikováno v: Current Oncology
Volume 17
Issue 2
Pages 422-68

The treatment of metastatic breast cancer is challenging. We recently assisted in the development of targeted therapies (in combination with chemotherapy or as monotherapy) that have improved results for selected groups of patients. Lapatinib is a du

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::febc0bfb7328d8b73f1f3f5a0725e803
https://doi.org/10.3747/co.v17i2.422

Zobrazit plný text záznamu

Isolated colorectal liver metastases locally progressing after stereotactic body radiotherapy rescued with surgery

Autor: A. Alberola Soler, J. B. Laforga Canales, F Peiró Monzó, V. Alberola Candel, J. Bertelli Puche, J. Gasent Blesa

Publikováno v: Current Oncology
Volume 16
Issue 5
Pages 360-80

Treatment of patients with metastatic colorectal cancer has changed in recent years, with many patients now being offered intent-to-treat regimens. In this context, a multidisciplinary approach to the metastatic disease may lead to individualized tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1d35a9e0cbe90bb079af12c21ecfe3

Zobrazit plný text záznamu

Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer

Autor: R, Pérez Carrión, V, Alberola Candel, F, Calabresi, R T, Michel, R, Santos, T, Delozier, P, Goss, L, Mauriac, F, Feuilhade, M, Freue

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 5

A total of 409 postmenopausal patients with advanced metastatic breast cancer were randomized to receive either formestane (Lentaron) 250 mg every 2 weeks by intramuscular injection, or tamoxifen 30 mg/day orally. Treatment continued until tumor prog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::810d6c8ccc1871d57f9e3c8e273eea4d
https://pubmed.ncbi.nlm.nih.gov/7873457

Zobrazit plný text záznamu

Effect of the response to first-line chemotherapy (chemo) in the chemotherapy-induced anemia control with the administration of Erithropoyetins (Epos) in metastatic non-small cell lung cancer (NSCLC) patients (pt)

Autor: M. Provencio Pulla, Oscar Juan, Vicent Giner-Bosch, Ana Grueso López, J. Gasent Blesa, V. Giner Marco, E. Grande Pulido, V. Alberola Candel

Publikováno v: Journal of Clinical Oncology. 27:e20647-e20647

e20647 Background: The aim of this retrospective study, is to measure the influence of the tumor control with chemo on the results of the chemo-induced anemia treatment with epos in pts with nsclc, that were non-anemic before chemo, and in whom the o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::160b8c362bff55cdecfdbdfee4b46a48
https://doi.org/10.1200/jco.2009.27.15_suppl.e20647

Zobrazit plný text záznamu

Neoadjuvant chemoradiotherapy in rectal cancer patients (pt) with oxaliplatin (Ox) and capecitabine (Cp): Results of a phase II trial

Autor: Oscar Juan, M. Provencio Pulla, I. Fernandez, V. Alberola Candel, C. Gravalos, C. Llorca, V. Giner Marco, J. Gasent Blesa

Publikováno v: Journal of Clinical Oncology. 27:e15101-e15101

e15101 Background: Between April 2006 and May 2008, 27 rectal adenocarcinoma pt were included (cT3: 25 pt, T4: 2 pt, N0: 11 Pt, N+: 16 pt), stages II-III, RMN staged, 14 male and 13 female. Mehtod: Neoadjuvant treatment was: Ox: 50 mg/m2 weekly, oral

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::37874cd2f896e67a66b4a9cd20b781e0
https://doi.org/10.1200/jco.2009.27.15_suppl.e15101

Zobrazit plný text záznamu

Predictive model of response to epoetin-alfa in anemic patients with solid tumors receiving chemotherapy: Results from a multicenter prospective study

Autor: O. Juan Vidal, V. Carañana, C. Molins, José Muñoz-Langa, J. M. Campos, S. Olmos, V. Alberola Candel, Carles Bosch, A. Albert, D. Almenar-Cubells

Publikováno v: Journal of Clinical Oncology. 26:20607-20607

20607 Background: The purpose of this prospective, multicenter study was to develop a model to predict hematopoietic response (HR) to epoetin alfa (EA) in anemic patients with solid tumors receivin...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09dcbf2193970d6d4ef8cfec329868c7
https://doi.org/10.1200/jco.2008.26.15_suppl.20607

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání